» Articles » PMID: 25742523

What Is the Optimum Timing of Postmastectomy Radiotherapy in Two-Stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant?

Overview
Specialty General Surgery
Date 2015 Mar 6
PMID 25742523
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Postmastectomy radiotherapy is increasingly common for patients with advanced breast cancer. The optimal timing and sequence of mastectomy, reconstruction, and radiotherapy remains unresolved for patients choosing immediate two-stage prosthetic reconstruction.

Methods: Long-term outcomes were compared for all patients with prosthetic-based reconstruction without radiation, radiation to the tissue expander, or to the permanent implant from 2003 to 2012 performed by the senior author (P.G.C.). Surgeon-evaluated outcomes included reconstructive failure, aesthetic results, and capsular contracture. Odds of failure with radiotherapy at different times were evaluated with logistic regression and Kaplan-Meier analysis. Patient-reported outcomes were assessed using the BREAST-Q.

Results: A total of 1486 reconstructions without radiation, 94 reconstructions with tissue expander radiation, and 210 reconstructions with permanent implant radiation were included. Six-year predicted failure rates were greater for patients with tissue expander radiation than for patients with permanent implant radiation (32 percent versus 16.4 percent; p < 0.01). Patients undergoing radiation to the tissue expander had a greater proportion of very good to excellent aesthetic results compared to patients with permanent implant radiation (75.0 percent versus 67.6 percent; p < 0.01) and lower rates of grade IV capsular contracture (p < 0.01). BREAST-Q scores were similar for patients with the different radiation timings.

Conclusions: Although the risk of reconstructive failure is significantly higher for patients with tissue expander radiation compared to patients with permanent implant radiation, the aesthetic results and capsular contracture rates are slightly better. Patient reported outcomes do not differ between patients with tissue expander or permanent implant radiation.

Clinical Question/level Of Evidence: Therapeutic, III.

Citing Articles

Effect of radiation timing on the capsular contracture of implant-based breast reconstruction: A retrospective cohort study.

Iwahira Y, Nakagami G, Morita K, Sanada H Medicine (Baltimore). 2025; 104(6):e41438.

PMID: 39928786 PMC: 11813055. DOI: 10.1097/MD.0000000000041438.


An Investigation of Gender Representation and Collaboration in Academic Plastic Surgery Research.

Chawla S, Rajendra J, Dhivagaran T, Ding J, Isaac K, Khosa F Plast Surg (Oakv). 2025; 33(1):186-192.

PMID: 39876850 PMC: 11770741. DOI: 10.1177/22925503231190928.


Effect of Radiotherapy on the Type and Timing of Breast Reconstruction After Mastectomy in Breast Cancer Patients.

Citgez B, Yigit B, Capkinoglu B, Altinkaya A Sisli Etfal Hastan Tıp Bul. 2025; 58(4):401-410.

PMID: 39816433 PMC: 11729833. DOI: 10.14744/SEMB.2024.34033.


Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients-current status and DEGRO recommendations.

Piroth M, Krug D, Baumann R, Strnad V, Borm K, Combs S Strahlenther Onkol. 2025; .

PMID: 39786586 DOI: 10.1007/s00066-024-02334-3.


Capsular Contracture After Postmastectomy Radiation in Implant-Based Breast Reconstruction: Effect of Implant Pocket and Two-Stage Surgery.

Moon S, Min K, Kim T, Um J, Kook Y, Baek S J Breast Cancer. 2025; 27(6):395-406.

PMID: 39761945 PMC: 11710909. DOI: 10.4048/jbc.2024.0141.


References
1.
Albornoz C, Matros E, McCarthy C, Klassen A, Cano S, Alderman A . Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction. Ann Surg Oncol. 2014; 21(7):2159-64. DOI: 10.1245/s10434-014-3483-2. View

2.
Overgaard M, Jensen M, Overgaard J, Hansen P, Rose C, Andersson M . Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999; 353(9165):1641-8. DOI: 10.1016/S0140-6736(98)09201-0. View

3.
Ragaz J, Jackson S, Le N, Plenderleith I, Spinelli J, Basco V . Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337(14):956-62. DOI: 10.1056/NEJM199710023371402. View

4.
Spear S, Baker Jr J . Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg. 1995; 96(5):1119-23; discussion 1124. View

5.
Overgaard M, Hansen P, Overgaard J, Rose C, Andersson M, Bach F . Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1998; 337(14):949-55. DOI: 10.1056/NEJM199710023371401. View